Immunetune is a biotech company that develops personalized DNA-based vaccines to treat highly mutated cancer types, including melanoma, lung, and colon cancer. It designs vaccines that train the immune system to selectively identify and eliminate tumor cells based on tumor-specific DNA mutations (neoantigens).